as on December 6, 2025 at 2:29 am IST
Day's Low
Day's High
0.79%
Downside
0.93%
Upside
52 Week's Low
52 Week's High
34.46%
Downside
1.90%
Upside
Check Gsk Plc-spon Adr. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$98.0B
EPS (TTM)
4.2654
Dividend Yield
3.45%
Quarterly Earnings Growth YOY
0.23%
PE Ratio (TTM)
13.8
Industry PE ratio
24.098333333333333
PEG Ratio
0.4276
EBITDA
9.5B
Revenue (TTM)
32.2B
Profit Margin
17.08%
Return On Equity TTM
41.52%
Track how Gsk Plc-spon Adr. P/E has moved over time to understand its valuation trends.
Gsk Plc-spon Adr. in the last 5 years
Lowest (8.78x)
March 31, 2025
Today (13.80x)
December 6, 2025
Industry (24.10x)
December 6, 2025
Highest (13.53x)
June 30, 2022
Today’s Price to Earnings Ratio: 13.80x
Compare market cap, revenue, PE, and other key metrics of Gsk Plc-spon Adr. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $98.0B | 3.27% | 13.8 | 17.08% | |
| BUY | $909.4B | 580.57% | 49.83 | 30.99% | |
| BUY | $404.2B | 110.74% | 174.59 | 4.00% | |
| BUY | $487.8B | 34.38% | 19.56 | 27.26% | |
| BUY | $252.0B | 21.7% | 13.35 | 29.63% |
The Gsk Plc-spon Adr. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Gsk Plc-spon Adr. investment value today
Current value as on today
₹1,45,916
Returns
₹45,916
(+45.92%)
Returns from Gsk Plc-spon Adr. Stock
₹39,977 (+39.98%)
Dollar Returns*
₹5,939 (+5.94%)
Based on 33 analysts
60.61%
Buy
30.30%
Hold
9.09%
Sell
Based on 33 analysts, 60.61% of analysts recommend a 'BUY' rating for Gsk Plc-spon Adr.. Average target price of $49.35
Get share price movements and forecasts by analysts on Gsk Plc-spon Adr..
What analysts predicted
1.95%UPSIDE
Target Price
$49.35
Current Price
$48.39
Analyzed by
33 Analysts
Target
$49.35
Gsk Plc-spon Adr. target price $49.35, a slight upside of 1.95% compared to current price of $48.39. According to 33 analysts rating.
Search interest for Gsk Plc-spon Adr. Stock has decreased by -3% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 26 November
Wed, 10:48 PM
-GSK pleased with agreement on lung disease medicines Trelegy and Breo, offering significant discounts.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
GSK Plc's revenue has been increasing over the last three quarters. It rose from $7.51 billion to $8.54 billion, showing an average growth of 6.2% each quarter.
Profit Spike
![]()
GSK Plc's net profit has shown positive growth over the last two quarters. In the most recent quarter, their net profit increased to $2.01 billion, up from $1.44 billion in the previous quarter. This reflects an average growth rate of 28.3% in net profit per quarter.
Price Rise
![]()
In the last 3 months, GSK stock has moved up by 19.5%
Best in 1 Year
![]()
In the last 1 year, GSK has outperformed top 5 stocks with highest market-cap in its industry
Best in 3 Years
![]()
In the last 3 years, GSK has outperformed top 5 stocks with highest market-cap in its industry
| Organisation | Gsk Plc-spon Adr. |
| Headquarters | 79 New Oxford Street, London, United Kingdom, WC1A 1DG |
| Industry | Health Technology |
| CEO | Ms. Emma Natasha Walmsley |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Emma Natasha Walmsley | CEO & Director |
Ms. Julie Belita Brown A.C.A. | CFO & Executive Director |
Mr. Tony Wood | Chief Scientific Officer and Head of R&D |
Mr. David Simon Redfern BSc (Hons), CA | President of Corporate Development |
Ms. Diana Conrad | Chief People Officer |
Dr. Jesse L. Goodman M.D., M.P.H. | Scientific & Medical Expert |
Ms. Shobie Ramakrishnan | Chief Digital & Technology Officer |
Mr. Constantin Fest | Senior VP & Head of Investor Relations |
Mr. James Ford | Senior VP & Group General Counsel of Legal & Compliance |
Ms. Sally Jackson | Senior VP of Global Communications & CEO Office |
Gsk Plc-spon Adr. share price today is $48.39 as on at the close of the market. Gsk Plc-spon Adr. share today touched a day high of $48.84 and a low of $48.01.
Gsk Plc-spon Adr. share touched a 52 week high of $49.31 on and a 52 week low of $31.72 on . Gsk Plc-spon Adr. stock price today i.e. is closed at $48.39,which is 1.87% down from its 52 week high and 52.58% up from its 52 week low.
Gsk Plc-spon Adr. market capitalisation is $0.10T as on .
Indian investors can start investing in Gsk Plc-spon Adr. (GSK) shares with as little as ₹89.896 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.96 in Gsk Plc-spon Adr. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Gsk Plc-spon Adr. share’s latest price of $48.39 as on December 6, 2025 at 2:29 am IST, you will get 0.2067 shares of Gsk Plc-spon Adr.. Learn more about
fractional shares .
Gsk Plc-spon Adr. stock has given 3.27% share price returns and 21.76% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?